Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. covers the period ending March 31, 2026. The report discloses a corporate action approved by the Board of Directors on March 30, 2026, regarding a capital increase resulting from the exercise of stock options under the Company's "First Program for the year of 2026 of the Company's Stock Option Plan."
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data disclosed relates to the capital increase transaction:
- Capital Increase Amount: BRL 33,127,274.55
- New Capital Stock Total: BRL 58,308,213,544.96
- Shares Issued: 2,026,133 new common shares (no par value)
- Issuance Price: BRL 16.35 per share
Material Changes
The material change reported is the expansion of the company's capital stock due to the issuance of 2,026,133 new common shares. This issuance was triggered by the exercise of stock options by certain beneficiaries. The filing does not provide comparative data against a prior period for operational metrics.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies beyond the specific disclosure of the capital increase. The transaction was executed pursuant to Article 6 of the Company's Bylaws and Article 168 of Brazilian Law No. 6,404/76.
Investor Verification Checklist
- Verify the impact of the 0.012855% potential dilution on existing share ownership.
- Confirm the total capital stock now stands at BRL 58,308,213,544.96.
- Review the terms of the "First Program for the year of 2026 of the Company's Stock Option Plan" approved on January 28, 2026.
- Note that this filing does not contain quarterly or annual financial results; investors should refer to Form 20-F for comprehensive financial data.